Cargando…
The ellipse of insignificance, a refined fragility index for ascertaining robustness of results in dichotomous outcome trials
There is increasing awareness throughout biomedical science that many results do not withstand the trials of repeat investigation. The growing abundance of medical literature has only increased the urgent need for tools to gauge the robustness and trustworthiness of published science. Dichotomous ou...
Autor principal: | Grimes, David Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586556/ https://www.ncbi.nlm.nih.gov/pubmed/36125120 http://dx.doi.org/10.7554/eLife.79573 |
Ejemplares similares
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
Publicado: (2021) -
Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study
por: Hughes, Amanda M, et al.
Publicado: (2022) -
A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients’ economic outcomes in Eswatini
por: Steinert, Janina Isabel, et al.
Publicado: (2020) -
How to improve patient safety in fragile, conflict-affected and vulnerable settings: a Delphi study protocol
por: Shaw, Alexandra, et al.
Publicado: (2021) -
Putting epigenetic biomarkers to the test for clinical trials
por: Justice, Jamie N, et al.
Publicado: (2020)